[1]
S. Sengupta, S. Sengupta, and S. Katare, “A real-world clinical experience on the effectiveness of remogliflozin etabonate in management of Indian patients with type II diabetes mellitus”, Int J Res Med Sci, vol. 9, no. 6, pp. 1722–1730, May 2021.